Completed OBSERVATIONAL NCT04353388

Sepsis Post Market Observational Study and Potential Reduction of Time to Antibiotics - Washington University

Post Market Observational Study of ESId (MDW Hematology Parameter) for Early Sepsis Detection in the Emergency Department (US Hospitals) and Potential Reduction in Time to Antibiotics - Washington University

Sponsor: Beckman Coulter, Inc.

Conditions Adult Disease Emergency Department Sepsis Severe Sepsis

Interventions CBC-DIFF Monocyte Volume Width Distribution (MDW)

Updated 6 times since 2020 Last updated: Mar 15, 2021 Started: Feb 3, 2020 Primary completion: Jul 17, 2020 Completion: Jul 17, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Adult Disease and Emergency Department, this trial is completed. The trial is conducted by Beckman Coulter, Inc. and has accumulated 6 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Apr 2021 [monthly]

Recruiting

▶ Show 1 earlier version

May 2020 — Jan 2021 [monthly]

Recruiting

First recorded

Feb 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beckman Coulter, Inc.

Data source: Beckman Coulter, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States